L About
Latent Labs develops generative AI models focused on de novo molecular design for applications in drug discovery and synthetic biology. Their core product suite, including models like Latent-X, Latent-X2, and Latent-Y, utilizes frontier AI to generate novel proteins, antibodies, and optimize existing enzymes at the atomic level. Founded in 2024, the company targets pharmaceutical and biotechnology partners, demonstrated by the lab validation of Latent-Y as a drug design agent.
Focus Areas
Technology Focus
drug discovery foundation models
Quick Stats
- Founded
- 2024
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
Chai Discovery
San Francisco, United States
88%
2 shared categories
2 shared AI types
Drug DiscoveryAI Research
Basecamp Research
London, United Kingdom
82%
2 shared categories
1 shared AI type
Same country
Drug DiscoveryAI Research
BenevolentAI
London, United Kingdom
76%
2 shared categories
1 shared AI type
Same country
Drug DiscoveryAI Research
Exscientia
Oxford, United Kingdom
76%
2 shared categories
1 shared AI type
Same country
Drug DiscoveryAI Research